Compare Multifiling Mitra Indonesia Tbk. (MFMI) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multifiling Mitra Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Multifiling Mitra Indonesia Tbk. trades at Rp1,300 (market cap 984.86B), while Charlie Hospital Semarang Tbk. trades at Rp430 (market cap 1.11T, 25.61M 24h volume). The key difference: Multifiling Mitra Indonesia Tbk. and Charlie Hospital Semarang Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| MFMI | RSCH | |
|---|---|---|
Market Cap | 984.86B | 1.11T |
Volume | — | 25.61M |
Lot | — | 256.07K |
Turnover | — | 10.76B |
Average Price | — | 420.16 |
Value | — | 10.76B |
Indicative Equilibrium Price | — | 430 |
Indicative Equilibrium Volume | — | 1.46K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multifiling Mitra Indonesia Tbk.
PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Read more on MFMI →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
